Suppr超能文献

过氧化氢预处理在间充质干细胞介导的心脏再生中的作用:分子见解。

Role of hydrogen peroxide preconditioning in mesenchymal stem cell-mediated heart regeneration: Molecular insights.

作者信息

Siraj Anum, Haneef Kanwal

机构信息

Dr. Zafar H. Zaidi Center for Proteomics, University of Karachi, Karachi 75270, Sindh, Pakistan.

出版信息

World J Cardiol. 2025 Aug 26;17(8):107437. doi: 10.4330/wjc.v17.i8.107437.

Abstract

Mesenchymal stem cells (MSCs) possess unique properties such as immunomodulation, paracrine actions, multilineage differentiation, and self-renewal. Therefore, MSC-based cell therapy is an innovative approach to treating various degenerative illnesses, including cardiovascular diseases. However, several challenges, including low transplant survival rates, low migration to the ischemic myocardium, and poor tissue retention, restrict the application of MSCs in clinical settings. These undesirable cell therapy outcomes mainly originated due to the overproduction of reactive oxygen species (ROS) in the injured heart. MSCs' stress-coping capacity can be enhanced by preconditioning them under conditions similar to the microenvironment of wounded tissues. Hydrogen peroxide (HO) is a ROS that has been shown to activate protective cellular mechanisms such as survival, proliferation, migration, paracrine effects, and differentiation at sublethal doses. These processes are induced phosphatidylinositol 3-kinase/protein kinase B, p38 mitogen-activated protein kinases, c-Jun N-terminal kinase, Janus kinase/signal transducer and activator of the transcription, Notch1, and Wnt signaling pathways. HO preconditioning could lead to many clinical benefits, including ischemic injury reduction, enhanced survival of cellular transplants, and tissue regeneration. In this review, we present an overview of stem cell preconditioning methods and the biological functions activated by HO preconditioning. Furthermore, this review explores the molecular mechanisms underlying the protective cellular functions stimulated under HO preconditioning.

摘要

间充质干细胞(MSCs)具有免疫调节、旁分泌作用、多谱系分化和自我更新等独特特性。因此,基于MSCs的细胞疗法是治疗包括心血管疾病在内的各种退行性疾病的一种创新方法。然而,包括低移植存活率、向缺血心肌的低迁移率和差的组织保留率等几个挑战限制了MSCs在临床环境中的应用。这些不良的细胞治疗结果主要源于受损心脏中活性氧(ROS)的过度产生。通过在类似于受伤组织微环境的条件下对MSCs进行预处理,可以增强其应激应对能力。过氧化氢(HO)是一种ROS,已被证明在亚致死剂量下可激活保护性细胞机制,如存活、增殖、迁移、旁分泌作用和分化。这些过程是由磷脂酰肌醇3-激酶/蛋白激酶B、p38丝裂原活化蛋白激酶、c-Jun氨基末端激酶、Janus激酶/信号转导和转录激活因子、Notch1和Wnt信号通路诱导的。HO预处理可带来许多临床益处,包括减少缺血损伤、提高细胞移植存活率和组织再生。在本综述中,我们概述了干细胞预处理方法以及HO预处理激活的生物学功能。此外,本综述探讨了HO预处理刺激的保护性细胞功能的分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9508/12426982/829c4adf7c2c/wjc-17-8-107437-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验